Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United States. Shares of Kenvue were up 18% in premarket trading, while Kimberly-Clark‘s shares were down 12.5%. Kenvue…
President Donald Trump’s tariffs are hitting toy giants Mattel and Hasbro as the critical holiday season nears. Still, both…
Target said Thursday that it is eliminating about 1,800 corporate positions in an effort to streamline decision-making and accelerate…
Card-reading contact lenses, X-ray poker tables, trays of poker chips that read cards, hacked shuffling machines that predict hands.…
A group that includes activist investor Jana Partners and NFL player Travis Kelce says it has accumulated one of…
The American cattle ranching industry is blasting President Donald Trump’s proposal to purchase beef from Argentina in an effort…
Customers of the athletic shoe company On have filed a class action lawsuit alleging that some of the brand’s…
MILAN — Giorgio Armani has appointed deputy managing director Giuseppe Marsocci as chief executive with immediate effect, the Italian…
LendingTree CEO and founder Doug Lebda died in an all-terrain vehicle accident over the weekend, the online loaning platform…